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Background: We presented abdominal liposarcoma cases diagnosed and managed in a tertiary care center and
also conducted a literature review on main features of this tumor.
Methods: Chart reviews of eight cases were conducted, and clinical, surgical, histopathological, and follow-up data
were recorded.
Results: Overall, complete surgical resection was performed with adjacent organ resection in 25% of cases, and
radiotherapy was not administered. Recurrence was developed in only one case and died after 2 years and 3
months, and other cases are under follow-up without recurrence. Histopatological examinations revealed findings
of well-differentiated liposarcoma.
Conclusions: According to our surgical experience, the surgical margin positivity may not be a determining factor
for the survival of patients with well-differentiated liposarcoma, and in the absence of macroscopic invasion,
adjacent organ resection may not be required. Radiotherapy may not be preferred when complete resection of
abdominal mass was achieved.
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Liposarcoma of abdomen is a rare lesion consisted of ma-
lign fat cells and accounts for approximately 20% of all
mesenchymal malignancies in adults. These lesions may be
found in different organs, typically occurs in either the ret-
roperitoneum or the extremities [1]. Abdominal liposarco-
mas are generally located in retroperitoneum; it is often
difficult to collect pathological samples nonsurgically. Sur-
gical exploration is needed for the final pathologic diagno-
sis. Retroperitoneal sarcomas tend to be high grade, except
liposarcomas, they tend to be low to intermediate grade.
Histologic grade is the main factor for survival rates in pa-
tients with liposarcomas [2]. Symptoms are usually non-
specific, and they do not appear until the tumor becomes
very large, a painless abdominal mass that enlarges in a
long period of time in an adult is most common history of
the patients. Metastases at the time of initial presentation* Correspondence: dr_caglaryildiz@yahoo.com
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unless otherwise stated.are uncommon [3]. Surgical treatment is the main modal-
ity in the therapy of retroperitoneal liposarcomas [3]. How-
ever, to our best knowledge, there is a small number of
case report or series related to abdominal liposarcoma.
The knowledge related to the clinical features and course
of retroperitoneal liposarcoma is mainly limited single-
institutional experiences. We presented cases with abdom-
inal liposarcoma managed in a tertiary care center and also
conducted a literature review on presentation, manage-
ment, and outcomes of these patients.Methods
Chart reviews of eight cases managed with liposarcoma
at the General Surgery Service of our tertiary care uni-
versity hospital were conducted between December 2011
and January 2014. This study was approved by the
Human Ethics Committee of our university. Clinical in-
formation regarding the age, gender, clinical findings,
imaging findings, surgical procedure, histopathology of
the tumor, follow-up findings, overall survival were re-
corded. Any imaging studies that had been obtainedl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 A midline abdominal incision dissection of the mass.
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raphy was used for imaging of abdomen in all patients
(Figure 1). A midline abdominal incision and sharp and
blunt dissection of the mass (Figures 2 and 3) was per-
formed and then intraoperative frozen section technique
was used to evaluate the margins of the tumoral mass for
all cases. The organs that involved macroscopically by the
tumor were excised (Figure 4). Tissue specimens were
processed by the hematoxylin-eosin staining method.
All the patients were followed up at 1, 3, 6, and 12
months and 6-month period in second year. Physical
and ultrasonographic examinations with laboratory tests
were performed in the third month, and a computerized
tomography was performed in the sixth month after sur-
gery. The median follow-up of 21 months (min.15,
max.24) with the shortest follow-up of 15 months and
longest follow-up of 24 months.
Results
Table 1 presents selected demographic, clinical, and in-
traoperative features of cases. Of eight patients, four pa-
tients were female and median age was 61.5 (21 to 73).
Overall, the most important clinical finding is palpable
abdominal mass and abdominal pain. During computed
tomography (CT) examination, we observed a large ab-
dominal mass about 28 to 50 cm in the largest size with
heterogeneous structure displacing adjacent organ and tis-
sues. Complete resection of mass was adequate as surgical
management in cases 1, 3, 5 to 8. In case 2, right nephrec-
tomy and right ureter resection were performed due to tu-
moral invasion, and a second surgery was also required for
local recurrence; however, histopathological diagnosis was
the same with other cases except case 4. In case 4, rightFigure 1 Computerized tomography was used for imaging of
abdomen in all patients.hemicolectomy, ileal resection, and partial bladder resec-
tion were added due to local invasion, and histopatho-
logical diagnosis was liposarcoma, well-differentiated, and
dedifferentiated (mixed) (Figure 5). The blood loss during
surgery was acceptable (150 to 220 mL), mean time for
surgical procedure was 140 min, and the duration of hos-
pital stay ranged from 4 to 6 days.
In almost all cases, histopatological examinations re-
vealed findings of well-differentiated and grade 1 liposar-
coma. Surgical margins were defined as positive in 75%
of cases and necrosis was detected in 25% of cases.
Recurrence has occurred in only one case and died
due to renal failure. Intraoperatively, in case 2, vena cava
inferior injury was developed and repaired. Four patients
had minor complication according to Clavien-Dindo
classification [4].Figure 3 Sharp and blunt dissection of the mass.
Figure 4 The organs that involved macroscopically by the tumor
were excised.
Karadayi et al. World Journal of Surgical Oncology  (2015) 13:166 Page 3 of 5Discussion
Eight patients with abdominal liposarcoma were presented
in this case series. Overall, complete surgical resection was
achieved with adjacent organ resection in 25% of cases.
We observed recurrence in only one case who died within
2 years and 3 months, and other cases are under follow-up
without recurrence. After median follow-up of 21 months
(min.15, max.24), all cases were alive without recurrence
except case 2 who survived 2 years and 3 months after first
surgery. Although radiotherapy was not administered to
our cases, there was no recurrence except case 2.
Liposarcoma is the most common mesenchymal tumor
of the retroperitoneal space but continues to pose a chal-
lenge with regard to diagnosis, prediction of clinical behav-
ior, and treatment of disease recurrence within the
abdominal/retroperitoneal space [5]. The major problem of
soft tissue sarcomas being present in the extremities like
retroperitoneum, chest wall, head and neck, and subcuta-
neous tissues is the other sites can be affected. Sarcomas
are a rare and heterogeneous group of malignant tumors
of mesenchymal origin that comprise all adult and child-
hood malignancies, respectively 1% and 12% [6,7]. Sarco-
mas constitutes one third of malignant tumors that arise in
the retroperitoneum, and approximately 10% to 15% of soft
tissue sarcomas arise in the retroperitoneum [8,9]. Mesen-
chymal cells of muscle, fat, and connective tissues are the
origins of sarcomas that arise from retroperitoneum.
The most commonly encountered histologic subtypes of
retroperitoneal sarcoma are liposarcoma (41%), leiomyosar-
coma (28%), malignant fibrous histiocytoma (7%), fibrosar-
coma (6%), and malignant peripheral nerve sheath tumor
(3%) [10]. Liposarcoma occurs in three main biologic forms:well-differentiated liposarcoma, myxoid and/or round cell,
and pleomorphic. In rare circumstances, lesions can have a
combination of morphologic types; these are classified as
combined or mixed-type liposarcomas. The most recent
World Health Organization classification of soft tissue tu-
mors recognizes five categories of liposarcomas: well differ-
entiated, which includes the adipocytic, sclerosing, and
inflammatory subtypes; dedifferentiated; myxoid; round cell;
and pleomorphic [11,12].
Well-differentiated (low-grade) liposarcomas are the
most common types of liposarcomas, followed by dediffer-
entiated liposarcomas. The amount of lipid inside the
cells, the mucoid lipid, and the degree of cell differenti-
ation are the essential of the classification. Myxoid, round
cell, and pleomorphic liposarcomas are rare in the retro-
peritoneum. Myxoid and round cell liposarcomas share
the same reciprocal translocation t(12,16)(q13; p11), in
which the CHOP gene is inserted adjacent to a novel gene
called FUS or TLS (translocated in liposarcoma). While
no specific chromosomal translocations have been identi-
fied in well differentiated/dedifferentiated liposarcomas,
amplification of MDM2 and CDK4 is very frequent in
these subtypes, and their identification may be useful diag-
nostically. Furthermore, overexpression of MDM2 and
CDK4 is also being exploited for therapeutic gain [12,13].
Liposarcomas are often asymptomatic until they reach to
large size in a long period of time before producing any
symptoms, and the complaints of patients are mainly re-
lated to direct invasion or compression of other adjacent
organs. There are no significant laboratory abnormalities
in the earlier stages and have often grown to a large size by
the time they are identified using a diagnostic modality
such as US or CT. CT of the abdomen is the most useful
tool in the imaging of retroperitoneum. CT of the chest is
very important for evaluating the lungs, as they are the first
site of metastasis in the most of cases. A CT scan allows
not only assessment of the tumor’s location and its rela-
tionship to adjacent organs but also identification of meta-
static lesions in the liver or peritoneal cavity [14]. CT is
less sensitive to motion artifact than magnetic resonance
image (MRI); because of this property, CT defines the ana-
tomic relationship of the tumor to other abdominal organs
better than the MRI. Liposarcoma of the abdominal region,
although rare, needs to be differentially diagnosed from
other abdominal tumors. Its symptoms are nonspecific,
and its diagnosis is intriguing. CT-scan or MRI are the
most useful tools for investigation and evaluation of retro-
peritoneal mass [14]. Surgery is the mainstay of treatment
for these cases and is curative with no recurrence following
complete surgical excision [15]. The final diagnosis should
always be confirmed with histopathology of the specimen.
We think that although in limited number, these described
cases can contribute to the great amount of controversy re-
garding surgical management of abdominal liposarcoma.
Table 1 Patient demographics and clinical and intraoperative findings
Patient number Age (y) Gender Clinical findings CT imaging findings Surgical procedures Survival after surgery
Case 1 43 F Palpable mass at left
lower quadrant
A 16 × 10 × 18-cm
heterogeneous pelvic
mass that extends up







Case 2 63 F Palpable mass of
abdomen, general
abdominal pain




and vena cava inferior.
During first surgery,
complete resection of






















Case 4 61 M Palpable mass of abdomen,
general abdominal pain







Case 5 28 M General abdominal pain,
abdominal swelling

















Case 7 66 M General abdominal pain,
abdominal swelling







Case 8 21 M General abdominal pain,
abdominal swelling
A 23 × 10 × 15-cm cystic
septated abdominal
mass at right lower





Y, year; F, female; M, male.
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liposarcoma. Complete surgical removal of retroperitoneal
tumor is the most effective treatment and has a significant
effect on the survival rate. The primary aim of the surgery
is complete resection with negative margins. However, inFigure 5 Histopatological examination of mixed-type liposarcoma tissue in ca
(HEX100). (C) Undifferentiated component (HEX100).many cases, it is not possible to perform complete resec-
tion because of the tumor being too large or invasive to
organs around it or its relation with the great vessels.
There is continuing research and debate on the use of
intraoperative radiotherapy (RT), adjuvant RT, preoperativese 4. (A) Well-differentiated component (HEX100). (B) Myxoid component
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operative chemoradiotherapy, preoperative chemotherapy,
and adjuvant chemotherapy. Many studies have shown that
a significant number of patients experience prolonged
disease-free survival when all grossly evident recurrent dis-
ease can be resected. Chemotherapy or radiotherapy ad-
ministration is still controversial in the treatment of locally
recurrent disease [14]. A phase III randomized controlled
trial has been completed yet about radiotherapy in patients
with primary soft tissue sarcoma of the retroperitoneum or
pelvis [16].
Because of the huge sizes of most retroperitoneal sar-
comas, the size of the tumor is not a predictor for sur-
vival of the disease. Tumor grade has been reported as a
significant factor in some studies, with the weight of evi-
dence supporting shorter recurrence-free and overall
survival for patients with high-grade tumors [17,18]. Me-
tastasis potential of liposarcomas is very low; because of
their tendency for local recurrence in the retroperito-
neum/mediastinum and spermatic cord, these same tu-
mors are referred to as well-differentiated liposarcomas
in these locations [7,19]. Well-differentiated liposarco-
mas are low-grade tumors; compared to dedifferentiated
high-grade liposarcomas, they have lower recurrence
rates, the potential to metastasize, and dedifferentiated
liposarcomas have a six-fold higher risk of death [5,19].
Overall, 5-year survival for well-differentiated subtypes
is 90%, while 5-year survival for pleomorphic subtypes
is only 30% to 50%. Dedifferentiated and myxoid/round
cell subtypes have 5-year survival rates of 75% and 60% to
90%, respectively [2]. Well-differentiated liposarcomas
may recur locally, but metastatic potential is low com-
pared with pleomorphic liposarcomas that have high
metastatic potential, and pleomorphic liposarcomas have
shorter survival than well-differentiated liposarcomas [5].
Conclusions
In summary, abdominal liposarcomas are low-grade tu-
mors in general and surgical excision with wide margin is
decreasing the effectiveness of the radiotherapy, increasing
the adverse effects especially on intestines. In our cases, al-
though surgical margin was reported as positive in 75% of
patients, because of the absence of macroscopic invasion,
adjacent organ resection was not performed. According to
our surgical experience, in patients with retroperitoneal
liposarcoma, surgical resection can be completed consid-
erably easy than expected although its size can be huge. In
almost all cases, absence of invasion to adjacent tissues
and organs is another advantage during surgical manage-
ment, adjacent organ resection should not be necessary
because of the low invasion potential of these tumors.
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